false
OasisLMS
Catalog
CHEST Guidelines
Table-of-Contents_chest (18)
Table-of-Contents_chest (18)
Back to course
Pdf Summary
The August 2020 issue of Volume 158 of CHEST features a wide array of research articles, editorials, and commentaries centered around advancements and discussions in pulmonary medicine. This issue covers various aspects of asthma diagnosis, with a specific focus on methacholine challenge testing, as well as the implications of spirometry performance in diagnosing asthma (pp. 433, 479).<br /><br />Chronic Obstructive Pulmonary Disease (COPD) management is explored, highlighting the association of guideline-recommended inhaler regimens with mortality and quality of life. Notably, a re-evaluation of the UPLIFT trial using age-appropriate criteria is included (pp. 529, 539).<br /><br />In critical care, articles discuss the timing of vasopressor administration in the ICU, with a study linking late administration to outcomes, and the correlation of ICU acuity with adherence to evidence-based care processes (pp. 571, 579). The edition also sheds light on COVID-19 impacts, discussing global reductions in transmission and its indirect benefits on respiratory health (pp. 467, 474).<br /><br />Research and discussions on pulmonary infections, especially post-endobronchial ultrasound procedures, are detailed, alongside a study on post-transplant management protocols (pp. 458, 523).<br /><br />Diffusion lung diseases receive attention through original research on interstitial lung disease prediction tools and air pollution's impact on idiopathic pulmonary fibrosis (pp. 620, 630). In thoracic oncology, the articles examine rurality in lung cancer treatment and validation of early-stage non-small cell lung cancer prognostic scores (pp. 787, 808).<br /><br />Sleep apnea and its cardiovascular implications are reviewed, with studies on sleep hypoxia's connection to heart failure and the effectiveness of CPAP devices (pp. 739, 751).<br /><br />Special features and correspondences address various topics from senotherapy in COPD to microRNAs in lung disease, contributing to ongoing conversations in pulmonary medicine. This issue offers clinicians and researchers comprehensive insights into current challenges and developments in respiratory healthcare.
Keywords
pulmonary medicine
asthma diagnosis
methacholine challenge
COPD management
ICU vasopressor timing
COVID-19 impacts
pulmonary infections
interstitial lung disease
lung cancer treatment
sleep apnea
×
Please select your language
1
English